-+ 0.00%
-+ 0.00%
-+ 0.00%

TELOMIR PHARMACEUTICALS - TO USE PROCEEDS FOR CLINICAL DEVELOPMENT OF TELOMIR-ZN AND PHASE 1/2 TNBC PROGRAM

路透·10/06/2026 12:00:07

请登录查看新闻详情